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Abstract
Aims:Melanoma is the most aggressive type of malignant skin cancer derived from uncontrolled proliferation of
melanocytes. Melanoma cells possess a high potential to metastasize, and the prognosis for advanced melanoma
is rather poor due to its strong resistance to conventional chemotherapeutics. Nanomaterials are at the cutting
edge of the rapidly developing area of nanomedicine. The potential of nanoparticles for use as carrier in cancer
drug delivery is infinite with novel applications constantly being tested. The noncarrier use of cerium oxide
nanoparticles (CNPs) is a novel and promising approach, as those particles per se show an anticancer activity via
their oxygen vacancy-mediated chemical reactivity. Results: In this study, the question was addressed of
whether the use of CNPs might be a valuable tool to counteract the invasive capacity and metastasis of mela-
noma cells in the future. Therefore, the effect of those nanoparticles on human melanoma cells was investigated
in vitro and in vivo. Concentrations of polymer-coated CNPs being nontoxic for stromal cells showed a cytotoxic,
proapoptotic, and anti-invasive capacity on melanoma cells. In vivo xenograft studies with immunodeficient
nude mice showed a decrease of tumor weight and volume after treatment with CNPs. Innovation: In summary,
the redox-active CNPs have selective pro-oxidative and antioxidative properties, and this study is the first to
show that CNPs prevent tumor growth in vivo. Conclusion: The application of redox-active CNPs may form the
basis of new paradigms in the treatment and prevention of cancers. Antioxid. Redox Signal. 19, 765–778.
Introduction
Reactive oxygen species (ROS) are byproducts of cellularmetabolism, generated primarily by mitochondrial ac-
tivity, other endogenous (52, 53) or exogenous sources such as
xenobiotics (25), cytostatics (49, 65), as well as UV radiation
(9). A variety of soluble factors stimulate the generation of
ROS, which via alterations of the intracellular redox state
and/or oxidative modification of proteins exert their action
on signaling components (59, 60). If not regulated properly by,
for example, antioxidants, excess ROS result in oxidative
stress, thus damaging cellular macromolecules and inhibiting
cellular functions that may result in some pathologies, in-
cluding cancer (47, 63).
The number of malignant melanoma being the most ag-
gressive type of skin cancer is rapidly increasing, suggesting a
doubling of the incidence every 10–20 years (18, 24). Although
surgical treatment of early melanoma leads to high cure rates,
the prognosis of 5-year survival for advanced melanoma is
rather poor (4), as a chronic increased level of ROS favors
survival and proliferation (16, 64). Those melanomas tend
to metastasize and show some resistance to classical treat-
ments (7). This reflects the current lack of therapeutic ap-
proaches for treating advanced melanoma (19). In addition,
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epidemiological studies showed an increased risk of secondary
cancers in individuals having a history of cutaneousmelanoma
(35). These facts pose a great challenge for finding new
approaches for the chemoprevention of the progression of that
type of cancer. Breaking ROS tolerance of melanoma cells by
either impairing their antioxidant system or further elevating
their intracellular ROS level by new therapeutics might hold a
future promise as an alternative therapeutical approach.
Nanomedicine, the medical application of nanotechnology,
deals with the application of structures < 100 nm as a valuable
set of research tools in anticancer therapy (15) in the near
future. A nanoparticle-based therapy may have the potential
as supplemental therapy supporting the classical anticancer
strategies. If future studies show that a nanoparticle-based
anticancer therapy is as effective as established therapies and
has less side effects, the application of nanoparticles as amajor
anticancer approach is conceivable. In earlier studies, vacancy
engineered cerium oxide (CeO2)-based nanoparticles ex-
hibited superoxide dismutase (SOD)- and catalase-mimetic
activity in a cell-free system (27, 44).
In this study, it was addressed whether polymer-coated
cerium oxide nanoparticles (CNPs) might be a valuable
therapeutical tool to combat invasive capacity and metastasis
of melanoma cells. For that, in vitro and in vivo studies were
performed, resulting in promising data.
Results
To decide on the use of uncoated or dextran-coated CNP as
a potential therapeutical tool to lower tumor invasion and
metastasis in vitro and in vivo, the effect of both types of these
nanoparticles on the expression of a-smooth muscle actin
(aSMA), a biomarker of myofibroblastic cells promoting tu-
mor invasion (13), and on the viability of tumor cells was
tested. Transforming growth factor (TGFb1) significantly in-
creased the amount of the aSMA protein compared to the
untreated controls. That TGFb1-mediated aSMA expression
could completely be abrogated by dextran-coated CNP, but
not uncoated CNP. The polymer dextran had no effect on
aSMA expression (Fig. 1A). These data indicate the use of
coated CNP to prevent a myofibroblast-dependent increase in
tumor invasion. Furthermore, the treatment of melanoma
cells with coated or uncoated CNPs increased cell death of the
tumor cells. However, it is interesting that the coated CNPs
showed a slightly stronger effect in context of cell toxicity (Fig.
1B). In conclusion, the dextran-coated nanoparticles showed a
more promising effect regarding the tested parameters.
Therefore, for further experiments, this study focused on
the importance of polymer-coated CNPs as a potential anti-
cancer agent for prevention of invasion of tumor cells in vivo
and in vitro.
The cytotoxicity and oxidative stress caused by 5-nm CeO2
nanoparticles in cultured human melanoma cells (A375) were
investigated. Concentrations of CNP being nontoxic on stro-
mal cells (e.g., fibroblasts and endothelial cells) showed sig-
nificantly decreased cell viability in tumor cells as a function
of nanoparticle concentration and exposure time. Indicators
Innovation
As both the incidence of melanoma is increasing faster
than that of other cancers, and the chemotherapeutical
treatment of a majority of patients with metastatic mela-
noma often results in adverse reactions and response rates
that are not high enough to significantly affect median
survival, novel therapeutical approaches must be the ob-
jective for the near future. In this study, we have shown for
the first time in vitro and in vivo that concentrations of
polymer-coated cerium oxide nanoparticles (CNPs) being
nontoxic for stromal cells exhibit a direct reactive oxy-
gen species-dependent cytotoxic (proapoptotic) and anti-
invasive effect on melanoma cells. Our study highlights a
prospective clinical significance of CNPs.
FIG. 1. Effect of coated versus uncoated cerium oxide
nanoparticles (CNP) in vitro. (A) Dextran-coated nano-
particles lower a-smooth muscle actin (aSMA) expression.
Subconfluent human dermal fibroblasts (HDFs) were either
mock-treated or pretreated for 48 h with 150 lm coated or
uncoated CNPs before addition of recombinant transforming
growth factor b1 (rTGFb1). TGFb1 and the cerium oxide
particles were present for an additional 48 h; a-tubulin was
used as a loading control. Three independent experiments
were performed. (B) Coated and uncoated nanoparticles
lower cell viability of melanoma cells. Subconfluent mela-
noma cells (A375) were treated with coated or with uncoated
CNPs or untreated (ct). The percentage of living cells after
96 h was measured by MTT assay. The experiments were
performed in two independent experiments with triplicates
in each group.
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of oxidative stress and apoptosis, including total ROS, car-
bonylated proteins, poly(ADP-ribose)polymerase (PARP)
cleavage, and caspase-3 activity, were quantitatively as-
sessed. It is concluded from the data that free oxygen radicals
generated by CeO2 nanoparticles produce significant oxida-
tive stress in tumor cells, resulting in a decrease in cell viability
and lowering of the invasive capacity of cancer cells.
Characterization and cellular uptake of CNP
The characteristics of nanoparticles such as size and shape are
crucial for determining their functional role in tumor cells.
Therefore, the synthesized particles were examined using high-
resolution transmission electron microscopy (HRTEM) to
determine particle size [Supplementary Fig. S1A(a); Supple-
mentaryData are available online atwww.liebertpub.com/ars].
Themicrographs showan individual particle size of*5nmand
depicting lattice fringes of CNP with a 0.31-nm selected area
electron diffraction pattern showing fluorite structure [Supple-
mentary Fig. S1A(b)].
Both, the coated and noncoated samples have a mixed
valance state of Ce3 + and Ce4 + on the surface with a stable
predominance of 4+ oxidation state for coated samples (ratio
Ce3 +/Ce4 + = 21/79) and a predominance of 3+ for noncoated
samples (ratio Ce3 +/Ce4 + = 67/33) (Supplementary Fig. S1B)
measured and calculated by X-ray spectroscopy. As for the
proposed SOD mimetic activity of CNPs (31), a higher per-
centage of Ce3 + is needed. For the subordinated catalase-
mimetic activity (3, 44), the lower percentage of Ce3 + of the
coated particles is sufficient (Supplementary Fig. S2C,D).
In addition, a slow reduction of freshly synthesized non-
coated CNPs upon aging in water for 7 days was confirmed
earlier (3), reflecting a change in the ratio of Ce4 +/Ce3 + to-
ward Ce3 + . The aging of nanoparticles in dextran does not
reduce CNPs to the same extent as the noncoated CNPs after 7
days of aging, indicating a stable Ce4 +/Ce3 + ratio toward
Ce4 + at a neutral pH.
Moreover, the dextran-coated nanoparticles have an added
advantage of stability in alkaline to the neutral medium in
contrast to noncoated particles that are stable in an acidic
medium only. Another significant advantage by coating these
particles with dextran is that the individual nanoparticles are
of the size 3–5 nm and do not agglomerate in suspension
(Supplementary Fig. S2A). HRTEM indicated no agglomera-
tion tendency over a period of 3 months (data not shown).
Taken together, the stable dextran-coated CNPswere used for
further studies.
A human melanoma cell line (A375) was used to demon-
strate the cellular uptake of the particles. Cells were treated
with fluorescein isothiocyanate (FITC)-labeled CNPs for 4 h
and, thereafter, prepared for visualization. The CNPs were
ubiquitously distributed in the cytosol [Supplementary Fig.
S1C(b)] comparedwith themock-treated control (a). TEMwas
used to confirm the presence of nanoceria in A375 cells as
well. The TEM micrographs of human melanoma cells show
CeO2 nanoparticles at 1 h upon treatment as solid black dots
localized in the cytosol [Supplementary Fig. S1C(d)].
Effect of CNP on tumor growth
and angiogenesis in vivo
To investigate the effect of CNP on human malignant
melanoma growth, A375 cells were injected subcutaneously
to the flank of nude mice to initiate tumor development
in vivo. Group 1 of six mice were untreated; group 2 was
treated with CNPs starting with day 1 post-tumor cell injec-
tion; and the last set (group 3) of tumor-cell-injected mice was
treated with CNPs starting with day 10 after injection. The
CNP was injected intraperitoneally every alternate day. After
dissection of tumors from mice after 30 days postinjection of
tumor cells, a significant lowered tumor growthwas observed
for both applications of CNPs (Fig. 2A). In contrast to mock-
treated controls, a significant smaller tumor volume of about
75% (1 d) and 85% (10 d) was determined after CNP treatment
(Fig. 2B). Furthermore, the tumor weight was significantly
reduced for both CNP applications of about 70% compared
with mock-treated tumor-bearing mice (Fig. 2C), indicating a
positive effect of CNP on inhibition of malignant melanoma
growth in vivo. At first view, it seemed not clear that why
there was no significant difference between a treatment with
CNP starting at day 1 (1 d) or day 10 (10 d) postinjection of
tumor cells. However, it depended on the experimental ap-
proach and on a delay in the initial growth of the injected
tumor cells. After a delay of growth in the order of 10 to 14
days showing some small nodules only, the growth of tumor
cells not treated with CNP dramatically increased for the rest
of the studied time period in contrast to CNP-treated tumor
cells. Therefore, the treatment with CNP starting at 1 or 10
days after tumor cell injection did not show a significant dif-
ference having a look on tumor volume or weight.
These data show for the first time in an in vivo model that
CNP may have the potential as an anticancer agent. In that
context earlier, published data show an alternate effect on
stromal cells, indicating the dual role of CNP, protective on
stromal cells, and damaging on tumor cells (2).
As many studies implicate tumor-associated blood vessel
formation as a central part in the process of growth, invasion,
and metastasis of malignancies (50), angiogenesis and tumor-
associated neovascularization are complex processes by
which new blood vessels are formed from pre-existing vas-
culature. To examine the effect of CNP on angiogenesis
in vivo, each tumor was subjected to immunohistological
analysis of CD31 (PECAM-1). CNP treatment starting with
day 1 and 10 after tumor cell injection in nude mice signifi-
cantly lowered (*60%) CD31 in the tumor sections com-
pared with the control group (Fig. 2D). These data indicate
an inhibiting effect of CNP on migration of endothelial cells
in the context to neovascularization, which correlates with a
lowered invasive capacity of CNP-treated endothelial cells in
an in vitro Matrigel assay (Supplementary Fig. S3). The most
widely used endothelial cell marker for studying angiogen-
esis/neovascularization is, for example, CD31 (PECAM-1).
CD31 is strongly expressed by all endothelial cells and
weakly expressed by several types of leukocytes (43). Stain-
ing of blood vessels with CD31 antibodies has been shown to
be suitable for the identification of angiogenesis in several
types of malignancies (23). According to the literature, the
density and morphological state of microvessels in a tumor
are closely correlated with prognosis and biological behavior.
Therefore, CNP can be considered as promising antitumor
agent.
On the basis of the promising results with the xenograft
model, we performed a set of in vitro experiments to get in-
sight into the underlyingmolecularmechanismmodulated by
CNP in melanoma.
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Effect of CNPs on cell proliferation
To examine a potential toxic effect of CNP, melanoma cells
were incubated with 5-nm-sized nanoparticles for 96 h. The
cell proliferation was analyzed by MTT assays. As shown in
Figure 3A, cell viability of A375 cells was decreased by
treatment with 150lM nanoceria for 96 h. A concentration
of 150 lM CNP was used, which was shown earlier (3) to
be nontoxic for normal cells, but having a cytotoxic effect
on squamous carcinoma cells. The cytotoxicity of polymer-
coated CNPs on stromal cells (human dermal fibro-
blasts [HDFs] and human microvascular endothelial cells
[HMEC-1]) was compared with melanoma cells (Fig. 3A). The
viability of normal cells was evidently not altered at 96h after
treatment with CNP, whereas melanoma cells showed a low-
ering of the viability by around 45%. However, no change of
cell viabilitywas observed for the three different cell types after
treatment with dextran only (mock-treated) compared with
untreated controls (ct). These results suggest that the cytotoxic
effect of the dextran-coated nanoparticles depends on the re-
dox-active CeO2 and is not affected by the polymer. Those
coated CNPs possess great selectivity between cancer and
normal cells, and they display potential application in
melanoma chemoprevention. In that context, the cytotoxic
FIG. 2. Inhibitory effect of
CNP on the growth of A375
xenografted mice. (A) Ima-
ges of dissected tumors. Three
groups of mice were used.
Group 1 is vehicle-treated
[mock-treated, (- )]; group 2 is
CNP-treated starting with
day 1 after tumor injection;
and group 3 is CNP-treated
starting with day 10 after tu-
mor injection. After 30 days,
the tumors were dissected. (B)
Tumor volume. The tumor
volume of six mice per group
was measured. **p < 0.01 ver-
sus ct (ANOVA andDunnett’s
test). Data are presented
as means– SD. (C) Tumor
weight. The tumor weight
of six mice per group was
measured. **p< 0.01 versus
ct (ANOVA and Dunnett’s
test). Data are presented as
means– SD. (D) H&E and
CD31 staining. Formalin-
fixed tissues were embedded
in paraffin and sectioned for
immunohistological analysis
of angiogenesis via CD31
staining and H&E staining for
morphology. The percentage
of CD31 staining is presented.
***p< 0.001 versus ct (ANOVA
and Dunnett’s test). Data are
presented as means– SEM.
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concentration values that cause destruction in 50% of the
proliferating cells (CC50) were determined being 166lM for
melanoma cells, and no toxicity was observed for CNP concen-
trations up to 1mM for fibroblasts and for the studied endo-
thelial cells. That data indicate a higher sensitivity of melanoma
cells against the polymer-coated nanoparticles (Fig. 3B).
Involvement of CNP in tumor invasion
As aSMA-expressing myofibroblasts (MF), often found at
the invasion front of many tumors (13), increase the invasive
capacity of tumor cells (10), the potential of CNP to prevent
invasion on melanoma cells was studied using the condi-
tioned medium (CM) of myofibroblasts (CMMF) and normal
fibroblasts (CMHDF), which were used as control. Therefore,
A375 melanoma cells were incubated with different concen-
trations of CNP. Forty-eight hours after treatment, the inva-
sive capacity of these cells and mock-treated control cells was
tested with CMHDF and CMMF (Fig. 3C). Indeed, the invasive
capacity of tumor cells is modulated by CNP. Compared to
mock-treated tumor cells, the invasive capacity of CNP-trea-
ted A375 cells was significantly lowered by 70% using both,
CMHDF and CMMF.
Modulation of ROS generation
and protein oxidation by CNP
To study a possible effect of nanoceria-initiated ROS on
toxicity and invasion of tumor cells, we assessed ROS gener-
ation both intracellularly and extracellularly. The intracellular
ROS level of HDFs was compared with the ROS level of A375
melanoma cells. The treatment of both HDFs and melanoma
cells resulted in a significant twofold increase in the ROS level
in the tumor cells, whereas no increase was detected in the
fibroblasts. Interestingly, the treatment of both cell types with
the chemotherapeutical ROS-producing drug doxorubicin
(14, 45), which was used as control, significantly increased the
intracellular ROS level in both cell types (Fig. 4A). These data
FIG. 3. Increased cytotoxicity and decreased invasion in CNP-treated tumor cells. (A) Cytotoxicity of cerium oxide (CeO2)
on normal and melanoma cells. Subconfluent melanoma cells (A375), HDFs, and human microvascular endothelial cells
(HMEC-1) were treated with CNP or with dextran only (mock-treated) or untreated (ct). The percentage of living cells after 96h
was measured by MTT assay. The experiments were performed in two independent experiments with triplicates in each group.
*p< 0.05 versus ct (Student’s t-test). (B) The CC50 value against melanoma cells. Subconfluent melanoma cells (A375) were
treated with various concentrations of CNP. The percentage of living cells after 96 h was measured by MTT assay. The
experiments were performed in three independent experiments. (C) Anti-invasive impact of CNP on melanoma cells. Sub-
confluent melanoma cells (A375) were treated with CNP or mock-treated before used for invasion assays. The invasive capacity
of these cells was tested with a conditioned medium of HDFs (CMHDF) and myofibroblasts (CMMF). The data represent the
mean– standard error of the mean (SEM) of three independent experiments. *p< 0.05 versus CMMF (Student’s t-test).
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FIG. 4. Increased reactive oxygen species (ROS) level and oxidative damage in CeO2-treated tumor cells. (A) Intracellular
generation of ROS by CNP. Subconfluent A375 and HDFs were serum-starved for 24 h. The cells were incubated with DCF
for 30min and then mock-treated, CNP-, or doxorubicin treated. The increase in DCF fluorescence as a measure of increase in
ROS was followed over 90min. Results are representative for two independent experiments with triplicates in each group. (B)
Pro-oxidant effect of CNP. Hydrogen peroxide (H2O2) was detected using the Amplex Red reagent. The data represent the
mean – SEM of three independent experiments. *p< 0.05 versus ct (ANOVA and Dunnett’s test). (C) Detection of CNP-induced
carbonylated proteins in vitro and in vivo; A375 cells were exposed to CNP for different time intervals before oxidized
proteins were detected by western blot analysis via derivatisation with 2,4-dinitrophenyl hydrazine. H2O2 was used as
positive control and a-tubulin as loading control (a). Three independent experiments were performed. Protein lysates pre-
pared from flash-frozen tissues of the xenograft mouse model were used in western blot procedures to assess generalized
protein oxidation (b). (D) Profiling sulfenic acid modifications in A375 cells. Protein was isolated from cells incubated in a
medium containing dimedone, in combination with H2O2 for 2 h or CNP for 24 h. Sulfenic acid-modified proteins were
analyzed by western blot with the a-hapten antibody. a-tubulin was used as loading control. Three independent experiments
were performed. (E) CNP treatment leads to ROS-dependent accumulation of hypoxia-inducible factor 1 alpha (HIF1a). A375
cells were treated with CNP for 24 h. Cobalt chloride (CoCl2), a hydroxylase inhibitor, was added for the last 4 h. The amount
of HIF1a protein was determined by western blot analysis. a-tubulin was used as loading control. Three independent
experiments were performed.
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suggest a pro-oxidant effect of CNP in tumor cells and a dif-
ferent sensitivity of tumor cells against CNP compared with
normal cells that could be a benefit of such nanoparticles in
the context of future therapeutical approaches. As CNP
treatment resulted in an intracellular increase in ROS in tumor
cells, a potential extracellular increase in hydrogen peroxide
(H2O2) should be measured with the chemically stable
fluorogenic probe N-acetyl-3,7-dihydroxyphenoxazine (Am-
plex Red), which is highly sensitive for the determination of
extracellular H2O2 (66).
CNP exposure resulted in a significant increase in peroxide
generation (Fig. 4B). A maximum of the H2O2 level was
measured 24 h after treatment of A375 melanoma cells with
CNP, which resulted in a 2.3-fold higher H2O2 amount com-
pared to mock-treated controls. A decrease of the H2O2
amount was observed between 24 and 48h. Melanoma cells
treated for 48 hwith CNP resulted in an up to a 1.6-fold higher
H2O2 level compared to mock-treated control. As the pro-
duction of H2O2 by CNP needs a superoxide source (31), the
effect of apocynin on the production of H2O2 was measured.
Apocynin, a methoxy-substituted catechol, inhibits NAD(P)H
oxidase by impeding the assembly of p47phox and p67phox
subunits within the membrane NAD(P)H oxidase complex
(54). Preincubation of melanoma cells for 1 h with apocynin
before CNP treatment downregulated the CNP-mediated
H2O2 generation, both at 24 and 48 h. However, it is evident
that CNP exposure results in a solid generation of H2O2.
Another, a more indirect, approach to measure the intra-
cellular generation of ROS and the occurrence of carbonylated
proteins, a biomarker for intracellular oxidative stress, was
detected. For that, A375 melanoma cells were treated with
CNP for 4–48 h and the carbonylated proteins verified. A low
amount of carbonylated proteins was detected in mock-
treated A375 cells, whereas the amount was significantly
increased in H2O2- and CNP-treated cells compared to mock-
treated cells after all studied time points [Fig. 4C(a)]. How-
ever, the highest amount of carbonylated proteins was
detected at 4 h post-treatment with CNP with a stepwise
lowering of the amount between 8 and 48h [Fig. 4C(a)].
Furthermore, protein lysates prepared from flash-frozen tis-
sues were used in western blot procedures to assess carbon-
ylation of proteins in tumor of mice. A high amount of
carbonylated proteins was detected in tumors of mice, which
were not treated with CNPs [Fig. 4C(b)]. CNP treatment
starting at day 1 and 10 after tumor cell injection in nude mice
and finished 30 days postinjection lowered the amount of
carbonylated proteins in the tumor lysates, compared to un-
treated mice. That lowered amount of oxidized proteins in
CNP-treated mice correlates with the cell culture data [Fig.
4C(a)] and is due to the time-dependent cytotoxic cell-killing
effect of CNP. In other words, a decrease in the cell number
results in a decrease of oxidized proteins. Even though the
occurrence of protein carbonyls offers a first hint for CNP-
initiated oxidative stress, the measurement of those carbonyls
is rather a general measure of an alteration of the cellular
redox status. Therefore, a more specific approach, namely, the
detection of oxidized thiol (-SOH) groups by H2O2 ( = sulfenic
acids), was used tomeasure a change in the intracellular redox
status. The application of an a-hapten antibody directed
against sulfenic acid of oxidized protein/peptide residues (51)
showed a significant increase in oxidized thiols at 24 h after
treatment with CNP compared to the diketone dimedone-
treated controls. In addition, treatment of the cells with ex-
ogenously added H2O2 resulted in a similar level of oxidized
thiol groups (Fig. 4D).
A further parameter for testing the pro-oxidant status
of cells is the accumulated translocation of the hypoxia-
inducible factor 1 alpha (HIF1a) to the nucleus (30) and the
expression of HIF1a target genes, including proangiogenic
factors and enzymes favoring a significant glycolytic metab-
olism (5, 48). Chemical inhibitors of the prolyl hydroxylase,
such as cobalt chloride (CoCl2), inhibit HIF1a degradation
and lead to its stabilization, therefore enhancing its detection
(42). Treatment of A375 cells with a nontoxic concentration of
100lMCoCl2 for 4 h resulted in a significant stability of HIF1a
protein levels (Fig. 4E). Treatment with either 50 or 150 lM
polymer-coated CNPs for 24 h led to an increase in HIF1a
protein expression compared with untreated control. Coin-
cubation of CNP and CoCl2 for 4 h showed an increased
HIF1a protein level, whichwas significantly higher than in the
CoCl2-treated controls.
As HIF1a positively affects the expression of glycolytic
enzymes resulting, for example, in a higher intracellular lac-
tate and H + production with a subsequent decrease of the
microenvironmental pH of tumor cells (22, 57), the question
was addressed of whether the pro-oxidant effect of CNP on
tumor cells may due to a higher lactate/H + production of
these cells versus (stromal) fibroblasts. Indeed, the A375 mel-
anoma cells produced up to 38% more lactate compared to
the fibroblasts (Supplementary Fig. S4). This increase in the
lactate and H + level explains the SOD-mimetic activity of
nanoceria [(a) Ce4þþO2/Ce3þ þO2, (b) Ce3þþ 2Hþþ
O2/Ce4þ þH2O2)], which was published earlier (3, 31).
The CNP-mediated increase in the intracellular ROS
level allows the conclusion that the change of the intracellu-
lar redox status in tumor cells may play an important role
in the increased cellular toxicity and lowering of the inva-
sive capacity. This hypothesis was checked in subsequent
experiments.
Induction of apoptosis by CNP
To assess whether the cytotoxic effect of polymer-coated
CNPs in melanoma cells was caused by ROS-mediated apo-
ptotic cell death, the occurrence of apoptotic biomarkers such
as cytochrome c release, caspase-3, and PARP cleavage was
measured.
The release of cytochrome c is an early event of the intrinsic
apoptotic cascade initiated, for example, by ROS (29). In that
context, treatment of the melanoma cells with H2O2 for 1 h
resulted in a significant increase of cytosolic cytochrome c
compared tomock-treated controls. A similar elevated level of
cytosolic cytochrome c was detected after treatment of the
tumor cells with CNP for 12 and 24 h (Fig. 5A). The CNP
treatment resulted in a 6.1-fold increase. As illustrated in
Figure 5B, the activity of caspase-3 was significantly increased
by CNP in A375 cells compared to mock-treated control cells.
At 24 h post-treatment with CNP, an up to 1.9-fold increase in
the caspase-3 activity was measured. Furthermore, the natu-
ralmaterial staurosporine, which induces caspase-3 activity in
melanoma cells (39), and which was used herein as positive
control, increased the activity of caspase-3.
In addition to the cytochrome c release and caspase-3
activity assay, PARP cleavage was evaluated. Caspase
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activation subsequently induces proteolytic cleavage of
PARP, which serves as a biochemical marker of cells under-
going apoptosis (8). CNP treatment for 24 h induced PARP
cleavage in melanoma cells compared to mock-treated con-
trol, which was demonstrated by the appearance of the 89-
kDa fragment (Fig. 5C). Treatment of the tumor cells with
exogenously added H2O2 resulted in PARP cleavage as well.
Apoptosis is initiated by two central mechanisms, the ex-
trinsic (36) and intrinsic pathway (41). Exposure of A375 cells
to CNP resulted in cytochrome c release, activation of caspase-
3, and PARP cleavage (Fig. 5A–C), which indicated the acti-
vation of the intrinsic pathway of apoptosis. In that context, it
is described that gold nanoparticles (AuNPs) resulted in a
significant increase in H2O2 generation, and thus apoptosis is
irreversibly induced (17). In conclusion, CNPs lead to a pro-
oxidant status of the tumor cells resulting in proapoptotic
mechanism.
Caveolin-1 downregulation by CNP
The role of ROS in the cellular invasion and migration was
described earlier (34, 55). Caveolin-1 (Cav-1) has received the
most attention, since its expression has been linked to cancer
progression and aggressiveness (58). Cav-1 plays a role not
only in cell death and survival, but also in cell migration (38)
and invasion (61). It is consistent that both H2O2 and super-
oxide (O2 ) have an inhibitory effect on expression of Cav-1,
while hydroxyl radicals increase Cav-1 expression and mi-
gration (38). Melanoma cells were treated with CNP for 1 h,
and Cav-1 expression was detected. CNP caused a significant
downregulation of Cav-1 expression compared to the mock-
treated control (Fig. 6). Incubation of the cells with exogenous
H2O2 for 1 and 4 h completely abrogated Cav-1 expression. By
contrast, pretreatment of melanoma cells with the antioxi-
dantN-acetyl-l-cysteine or apocynin resulted in an increased
Cav-1 expression compared to CNP-treated cells. These data
indicate the involvement of CNP-initiated ROS in lowering
the invasive capacity of the studied tumor cells.
FIG. 5. CNP treatment caused apoptosis in A375 cells. (A)
Subcellular distribution of cytochrome c. Subconfluent A375
cells were either mock-treated or incubated for 12 and 24 h;
CNP and cytochrome c levels were determined by western
blot in the cytosolic fraction. H2O2was used as positive control
and a-tubulin as a loading control. Three independent exper-
iments were performed. (B) Increased Caspase-3 activity in
melanoma cells. Caspase-3 activity was measured using a
fluorometric caspase-specific substrate (Ac-DEVD-AMC).
Staurosporine was used as positive control. Results represent
the means of three separate experiments, and error bars
represent SEM. Statistical significance was shown by the
Student’s t-test versus ct (*p< 0.05). (C) Cleavage of poly(ADP-
ribose) polymerase (PARP). Representative western blot
shows PARP cleavage after incubation of melanoma cells for
24h with CNP compared to mock-treated control (ct). H2O2
was used as positive control and a-tubulin as loading control.
Three independent experiments were performed.
FIG. 6. Expression of caveolin-1 (Cav-1) in melanoma
cells. Representative western blot demonstrates Cav-1 pro-
tein expression in A375 cells mock-treated, CNP treated for
24 h, or preincubated with apocynin for 1 h or N-acetyl-l-
cysteine for 4 h, and then CNP treated for 24 h. H2O2 was
used as a positive control and a-tubulin as a loading control.
Three independent experiments were performed.
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Discussion
As both the incidence of melanoma is increasing faster than
that of other cancers and the chemotherapeutical treatment of
a majority of patients with metastatic melanoma often results
in adverse reactions and response rates that are not high en-
ough to significantly affect median survival, novel ther-
apeutical approaches should be the objective for the near
future. In this study, we have shown for the first time in vitro
and in vivo that concentrations of polymer-coated CNPs being
nontoxic for stromal cells exhibit a direct ROS-dependent
cytotoxic (proapoptotic) and anti-invasive effect on mela-
noma cells. Our study highlights a prospective clinical sig-
nificance of polymer-coated CNPs.
Recently, a number of studies have focused on the inter-
action between nanoparticles and biological systems to
evaluate novel strategies for an efficient drug delivery and
possible alternative cancer therapies. Magnetic iron nano-
particles, for example, are used in cancer therapy. Cancer cells
incubated with these particles and then magnetically heated
show decreased viability, whereas normal cells remain unaf-
fected (32). Polymer-coated CNPswith a size of ø20 nm and in
higher concentrations then used herein generate free oxygen
species in human lung cancer cells and produce significant
oxidative stress and subsequent decrease in the cell viability
(37). However, the effect of that high concentration of CNP on
normal (stromal) cells was not studied. We described earlier
that CNPs with a smaller size and lower concentration result
in an antioxidant and protective effect in (stromal) fibroblasts
(3). CNPs (nanoceria) have a unique electronic structure that
is mediated by their large surface-area-to-volume ratio (28),
resulting in valance and oxygen defects on the surface of that
particles. Therefore, nanoceria possess a promising pharma-
cological potential, suggesting that nanoceria may be used as
an antioxidant agent (11). The antioxidant ability is associated
with the SOD-mimetic (21, 31) and catalase-mimetic activities
(44) of nanoceria that were measured primarily in a cell-free
system. Recently, we published an antioxidative activity of
CNPs in normal cells and, surprisingly, a pro-oxidant effect in
cells of a squamous skin tumor (3). In that context, the data
presented herein with melanoma cells support a pro-oxidant
(SOD-mimetic) mechanism of nanoceria that depends on the
pH of the cells. As a higher lactate/H + production was de-
tected in A375 cells (see Supplementary Fig. S3), the following
chemical mechanisms are suggested: (a) Ce4þ þO2/
Ce3þ þO2 and (b) Ce3þ þ 2Hþ þO2/Ce4þþH2O2). As
Figure 4A and B indicate a production of superoxide and an
increase in H2O2 in the melanoma cells and Supplementary
Figure S1B shows a higher percentage of Ce4 + in coated na-
noparticles, which is important for the initial SOD-mimetic
mechanism, these results in accordance with earlier published
data support the proposed pro-oxidant effect of polymer-
coated CNPs. That pro-oxidant effect results in cytotoxicity
and decrease of the invasive capacity of the tumor cells.
Materials and Methods
The cell culture medium (Dulbecco’s modified Eagle’s
medium [DMEM]) was purchased from Invitrogen, and the
defined fetal calf serum (FCS gold) was from PAA Labora-
tories. All chemicals, including protease as well as phospha-
tase inhibitor cocktail 1 and 2, were obtained from Sigma or
Merck Biosciences unless otherwise stated. The protein assay
kit (Bio-Rad DC; detergent-compatible) was from BioRad
Laboratories. Matrigel and polycarbonate cell culture inserts
(6.5-mm diameter; 8-lm pore size) were delivered from BD
Biosciences. The Oxyblot Protein Oxidation Detection kit was
from Millipore, whereas the Amplex Red Hydrogen Per-
oxide/Peroxidase Assay Kit was provided from Invitrogen.
The enhanced chemiluminescence system (SuperSignal West
Pico/FemtoMaximum Sensitivity Substrate) was supplied by
Pierce. Monoclonal mouse antibody raised against human
aSMA and a-tubulin was supplied by Sigma. Polyclonal
rabbit antibody raised against human HIF1a and Cav-1 was
supplied by New England Biolabs. The polyclonal rabbit a-
hapten antibody directed against oxidized thiol groups (sul-
fenic acid) (50) was a gift from Kate S. Carrol’s group. The
following secondary antibodies were used: polyclonal
horseradish peroxidase (HRP)-conjugated rabbit anti-mouse
IgG antibody (Dako) and goat anti-rabbit immunoglobulin G
antibodies, which were from Dianova. Recombinant human
TGFb1 (rTGFb1) was from R&D Systems.
Cell culture
HDFs were established by outgrowth from foreskin biop-
sies of healthy human donors with an age of 3–6 years. Cells
were used in passages 2–12, corresponding to cumulative
population-doubling levels of 3–27 (6). The human malignant
melanoma cell line A375, originally derived from a 54-year-
old woman, was purchased from ATCC (20). The immortal-
ized HMEC-1, which expresses cell surface molecules typi-
cally associated with primary endothelial cells, was obtained
from the Centers for Disease Control (1). Dermal fibroblasts,
melanoma, and endothelial cells were cultured as described
(56). MF were generated by treatment of HDFs with rTGFb1
for 48 h in CMHDF (10).
Preparation of CM
The CM was obtained from HDFs (CMHDF) and myofi-
broblasts (CMMF). For this, seeded 1.5 · 106 HDFswere grown
to subconfluence (*70% confluence) in 175-cm2 culture
flasks. The serum-containingmediumwas removed, and after
washing in phosphate-buffered saline (PBS), the cells were
treated with 5 ng/ml or without rTGFb1 in a serum-
free DMEM for 48 h. This medium was removed, and after
washing in PBS, all cells were incubated in 15ml serum-free
DMEM for further 48 h before collection of the CMHDF and
CMMF. The CMwas freshly used or stored at - 20C for at the
most 2 weeks before use.
Cell viability
The cytotoxic effect of CNPs was measured by MTT [3-(4,
5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide]
assay (40). The activity of mitochondrial dehydrogenases, as
indicator of cellular viability, results in the formation of a
purple formazan dye. Briefly, the MTT solution (0.5mg/ml)
was added to the cells treated with different concentrations of
CNPs for 96 h after washing with PBS. The medium was re-
moved, and the cells were lysed in dimethyl sulfoxide. The
formazan formation was measured at 570 nm. The results
were presented as a percentage of mock-treated control,
which was set at 100%. The CC50 value was defined as the
concentration that reduced the absorbance of treated cells to
50% when compared to mock-treated (control) cells.
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Synthesis of CNPs
CNPs were synthesized in dextran (molecular weight: 1000
Da) using previously described methods (26). Briefly, cerium
nitrate hexahydratewas dissolved in deionizedwater, and the
pH of the solution was maintained between 3.5 and 4.0
for uncoated (water-based) nanoparticles. Stoichiometric
amounts of H2O2 and ammonium hydroxide were added to
oxidize the dissolved cerium ions as CNPs. The pH of the
solution needs to be maintained strictly below 4.0 to avoid
precipitation of the nanoparticles. For synthesis of dextran-
coated nanoparticles, a stoichiometric amount of dextran
(5mM) was at first dissolved in deionized water (18.2MO)
followed by cerium nitrate hexahydrate. The solution was
stirred for 2 h followed by addition of ammonium hydroxide
(30%w/w) to oxidize the dissolved cerium ions as CNPs. The
pH of the solutionwas kept below 9.5 to avoid precipitation of
cerium hydroxide. The resulting dextran-coated CNPs (na-
noceria) were analyzed using UV–Visible spectroscopy for
determining the oxidation state of nanoparticles. TEM and
dynamic light scattering were used to determine the particle
size and hydrodynamic radius of the nanoparticles. Catalase
and SOD activity was determined as described in our previ-
ous publication (3). After preparation of dex-CNP, we dia-
lyzed the solution to remove excess dextran for 48 h against
dH2O using a 1200-molecular-weight cut-off dialysis mem-
brane, and then Fourier transform infrared spectroscopy
(FTIR)was carried out to confirm coating/presence of dextran
on the surface of CNP. FTIR data of bare CNP, dextran, and
dextran-CNP are shown in Supplementary Figure S5. FTIR
data confirm the presence of dextran coating on the surface of
the CNP. FTIR spectra were collected to confirm the dextran
molecule on the nanoparticle surface using PerkinElmer
Lamda750S and PerkinElmer Spectrum.
High-resolution TEM
High-resolution transmission electron micrographs were
obtained using an FEI Tecnai F 30 microscope operated at
300 kVwith a point-to-point resolution of 0.2 nm. The samples
were prepared by depositing a drop of dextran-coated CNP
on a holy carbon-coated copper grid. The grids were dried
overnight in vacuum before imaging.
X-ray spectroscopy
X-ray photoelectron spectroscope (XPS) spectra of Ce(3d)
were collected using a 5400 PHI ESCA (XPS) spectrometer,
and Mg-Ka X-radiation (1253.6 eV) at a power of 350 watts
was used during the data collection. Ce4 +/Ce3 + oxidation
state ratio on the surface of bare and dextran-coated CNPs
was analyzed by deconvoluting the XPS spectrum of Ce(3d),
as described elsewhere (12). The peaks at 880.8, 885.8, 899.3,
and 903.5 eV corresponding to the Ce3 + oxidation state and
peaks at 881.9, 888.4, 897.9, 901.2, 906.8, and 916.3 eV corre-
sponding to the Ce4 + were assigned. Intensities of the peaks
were determined, and the Ce3 +/Ce4 + ratios calculated.
Cellular uptake of nanoparticles
Human melanoma cells in a serum-free DMEM were
treated with 150 lM CNP for 4 h. Thereafter, cells were har-
vested and washed with PBS to remove the excess medium.
As CNP is not detectable by phase-contrast microscopy, TEM
was used to determine the cellular uptake of nanoceria. For
electron microscopy, pelleted samples of CNP-treated cells
were fixed for 2 h in 4% paraformaldehyde and 2.5% glutar-
aldehyde (Serva) in 0.1M phosphate buffer at pH 7.4 at room
temperature. Next, the pellets were thoroughly washed with
four changes of PBS, followed by a postfixation for 60min in
1% osmium tetroxide (Serva) in PBS. The specimens were
dehydrated in a graded series of acetone, and embedded in
Spurr’s medium (Serva) at 70C for 24 h. Ultrathin sections
were cut from the embedded tissue with a Reichert Ultracut
using a diamond knife. The sections were collected on coated
copper grids, and subsequently stained with uranyl acetate
and lead citrate according to earlier published data (46). The
grids were analyzed using a Hitachi H 600 electron micro-
scope. An optical system and Digital Micrograph software
(Gatan) were used for documentation. For light-microscopical
controls, semithin sections were cut and stained with 1% to-
luidine blue and 1% borax.
For fluorescence microscopy, cells were incubated with
150 lM FITC-labeled CNPs for 4 h or mock-treated. There-
after, cells were washed twice with PBS and fixed with
methanol. For preparation, ProLong Gold (Invitrogen) was
used, a reagent that simultaneously stains the nuclei with
DAPI. Zeiss Axiovert 100TV was used for the fluores-
cence microscopic examination, and a digital camera system
(Hamamatsu C4742-95) for documentation.
Sodium dodecyl sulfate–polyacrylamide gel
electrophoresis and western blotting
Sodium dodecyl sulfate–polyacrylamide gel electrophore-
sis (SDS-PAGE) was performed according to the standard
protocols published elsewhere (33) with minor modifications.
Briefly, cells were lysed after incubation with CNP in 1% SDS
with 1:1000 protease inhibitor cocktail (Sigma). After sonica-
tion, the protein concentration was determined by using a
modified Lowrymethod (Bio-RadDC); 4· SDS-PAGE sample
buffer (1.5M Tris–HCl, pH 6.8, 6ml 20% SDS, 30ml glycerol,
15ml b-mercaptoethanol, and 1.8mg bromophenol blue) was
added, and after heating, the samples (20–30 lg total protein/
lane) were applied to 8%–15% (w/v) SDS–polyacrylamide
gels. After electroblotting, immunodetection was carried out
(1:1000 dilution of primary antibodies, rabbit monoclonal
anti-aSMA, HIF1a , Cav-1, and mouse monoclonal anti-a-
tubulin; and 1:20,000 dilution of anti-mouse/rabbit antibody
conjugated to HRP). Antigen–antibody complexes were
visualized by an enhanced chemiluminescence system.
a-tubulin was used as internal control for equal loading.
A375 xenograft model of nude mice
One million human melanoma A375 cells (1· 106) were
resuspended in 50 ll PBS, mixed with 200 ll Matrigel (BD
Biosciences), and implanted subcutaneously into the right
flank of 6–7 weeks old athymic NCr-nu/nu mice from the
National Cancer Institute (NCI). The care and experimental
manipulation of mice described in this study were in accor-
dance with the guidelines of the Mayo Clinic College of
Medicine for the ethical treatment of animals. To distinguish
between individual differences in mice, six mice were chosen
for each group. Group 1 is vehicle-treated [ =mock-treated
(0.1mg dextran/kg body weight)]; group 2 is CNP-treated
starting with day 1 after tumor cells were injected; and group
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3 is CNP-treated starting with day 10 postinjection of tumor
cells. Nanoceria was administered by intraperitoneal injec-
tion, every alternate day with the dose of 0.1mg/kg body
weight for 30 days. The day after the last CNP application, the
tumor was dissected, and its weight recorded. Three diame-
ters of the tumor (L, B, andH) weremeasured by a caliper. The
volume of the tumorwas calculated asV =p/6 ·L ·B ·H (62).
Immunohistochemistry/histology
Tumor angiogenesis was assessed by CD31/PECAM-1
(Platelet Endothelial Cell Adhesion Molecule-1) staining of
paraffin tissue sections employing a rat monoclonal antibody
(Dianova), a biotinylated secondary antibody (Biotin Goat
anti-Rat Ig; BD Pharmingen), and streptavidin/peroxidase
and diaminobenzidine/H2O2 (Dako). CD31 staining
was quantitated by image analysis using GraphPad Prism
software.
Measurement of extracellular and intracellular ROS
The generation of ROS was determined using the Amplex
Red Hydrogen Peroxide/Peroxidase Assay Kit. The Amplex
Red reagent (10-acetyl-3,7-dihydroxyphenoaxine), in combi-
nation with HRP, can be used to detect H2O2 released from
cells. H2O2-mediated oxidation of the reagent results in the
fluorescent product resorufin. Subconfluent A375 tumor cells
were treated with 150 lM CNP or preincubated with 1mM
apocynin in a serum-free DMEM in 96-well plates for different
time points. Untreated subconfluent A375 cells were used as
negative controls. After incubation with CNP, cells were
washed twice with Hank’s balanced salt solution (HBSS), and
the assay was performed following the manufacturer’s in-
structions. Resorufin fluorescence was detected at an excita-
tion wavelength of 520 nm and emission wavelength of
590 nm in a FLUOstar OPTIMA plate reader (BMG Labtech).
Mean fluorescence intensities and standard error of mean
(SEM)were determined by using statistical software Prism 3.0
(GraphPad). Furthermore, the generation of intracellular ROS
was determined using 2¢,7¢-dichlorodihydrofluorescein dia-
cetate (H2DCF-DA), a dye that diffuses across the lipid
membranes into cells and is subsequently oxidized by intra-
cellular ROS forming the highly fluorescent DCF. Untreated
subconfluent HDFs and melanoma cells (A375) were used as
negative controls. The medium was substituted after 24-h
starvation by 100 lMH2DCF-DA containing HBSS for 30min.
Subconfluent HDFs and A375 tumor cells were exposed to
150 lM CNP and 5lM doxorubicin in the serum-free DMEM
in 24-well plates, and DCF fluorescence was detected at an
excitation wavelength of 485 nm and emission wavelength of
520 nm in 5-min intervals for 90min in a FLUOstar OPTIMA
plate reader (BMG Labtech). Mean fluorescence intensities
and SEM were determined for each reading point by using
statistical software Prism 3.0 (GraphPad), and the end point is
shown.
Determination of oxidized (carbonylated) proteins
A375 melanoma cells were grown to subconfluence on
tissue culture dishes. After removal of the serum-containing
medium, cells were cultured in a serum-free medium and
either mock-treated or treated for different time periods with
150 lM CeO2 nanoparticles. As a positive control, the cells
were treated with 250 lM H2O2. Thereafter, cells were lysed
and carbonyl groups of oxidized proteins were detected with
the OxyBlot Protein Oxidation Detection Kit, following the
manufacturer‘s protocol. Briefly, the protein concentration
was determined by using a modified Lowry method (Bio-Rad
DC). Five lg of the cell lysates was incubated with 2,4-
dinitrophenyl (DNP) hydrazine to form the DNP hydrazone
derivatives. Labeled proteins were separated by SDS-PAGE
and immunostained using rabbit anti-DNP antiserum (1:500)
and goat anti-rabbit IgG conjugated to HRP (1:2000). Blots
were developed by enhanced chemiluminescence.
Determination of oxidized thiol groups (sulfenic acid)
A375 melanoma cells were grown to subconfluence on
tissue culture dishes. After removal of serum-containing me-
dium, cells were cultured in serum-free medium and either
mock-treated or treated for 24 h 150lM CeO2 nanoparticles
and the last 2 hwith 10mM dimedone. As positive control, the
cells were coincubated with 10mM dimedone and 1mM
H2O2 for 2 h. Cells were harvested and washed with PBS, and
lysates were generated and analyzed with the a-hapten
(1:1000) antibody directed against oxidized –SH groups by
western blot analysis.
Invasion assay
Cell culture inserts (transwells) were overlaid with 125lg/
ml growth factor-reduced Matrigel and placed in a 24-well
plate. A375 tumor cells (5· 104 cells/insert) either mock-
treated or pretreated with 150 lM CNPwere seeded on top of
the Matrigel in a serum-free DMEM. CMHDF and CMMF (see
above) were used as chemoattractants in the lower chamber.
After 30 h at 37C, the melanoma cells were rubbed off the
upper side of the filter using cotton swabs, and the A375 cells,
which invaded toward the lower side of the insert, were
stainedwith Coomassie Blue solution (0.05%Coomassie Blue,
20% MeOH, and 7.5% acetic acid). The number of invaded
cells was estimated by counting random microscopic fields/
insert.
L-lactate assay
A375 melanoma cells and HDFs were grown to sub-
confluence on tissue culture dishes. After removal of the
serum-containing medium, cells were cultured in a serum-
free medium for 24 h. Thereafter, cells were collected by cen-
trifugation (1500 g for 10min at 4C). The supernatant was
used to quantify extracellular l-lactate with the l-Lactate
Assay Kit from Cayman Chemical Company following the
manufacturer’s protocol.
Caspase-3 activity assay
A375 melanoma cells and HDFs were grown to subcon-
fluence on tissue culture dishes. After removal of the serum-
containing medium, cells were cultured in a serum-free
medium with 150lM CNP or 100 nM staurosporine for 24 h.
Cell pellets were suspended in a cell lysis buffer and incu-
bated on ice for 45min. The lysate was vortexed every 15min.
After centrifugation at 11000 g for 15min, supernatants were
collected and immediately measured for protein concentra-
tion and caspase activity. Briefly, cell lysates (20 lg protein)
were placed in 96-well plates, and then the specific caspase
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substrate (Ac-DEVD-AMC for caspase-3) was added. Plates
were incubated at 37C for 1 h, and caspase activity was de-
termined by fluorescence intensity with the excitation and
emission wavelengths set at 380 and 440 nm, respectively.
Statistical analysis
Means were calculated from at least three independent
experiments, and error bars represent SEM. Analysis of sta-
tistical significance was performed by Student’s t-test or
ANOVA with *p< 0.05, **p < 0.01, and ***p < 0.001 as levels of
significance.
Acknowledgments
This work is part of the PhD thesis of M.S. at the Heinrich-
Heine-University of Du¨sseldorf. We thank C. Wyrich, V.
Pu¨tzer, and B. Rohbeck for excellent technical assistance. S.
Seal acknowledges the National Science Foundation (NSF) to
partially fund the nanotechnology research under NSF NIRT
(CBET-0708172) and NSF (CBET-0930170). We would like to
thank Candice E. Paulsen and Kate S. Karrol for providing the
a-hapten antibody.
Author Disclosure Statement
The authors declare no competing financial interests.
References
1. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S,
Bosse DC, and Lawley TJ. HMEC-1: establishment of an
immortalized human microvascular endothelial cell line.
J Invest Dermatol 99: 683–690, 1992.
2. Alili L, Karakoti AS, Seal S, and Brenneisen P. Suppression
of tumor invasion by inorganic nanoparticles Cancer Res
69(23 Suppl.): Boston, C42, 2009.
3. Alili L, Sack M, Karakoti AS, Teuber S, Puschmann K, Hirst
SM, Reilly CM, Zanger K, Stahl W, Das S, Seal S, and
Brenneisen P. Combined cytotoxic and anti-invasive prop-
erties of redox-active nanoparticles in tumor-stroma inter-
actions. Biomaterials 32: 2918–2929, 2011.
4. Altekruse SF, KC, Krapcho M, Neyman N, Aminou R,
Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H,
Mariotto A, Eisner MP, Lewis DR, Cronin K, Chen HS, Feuer
EJ, Stinchcomb DG, and Edwards BK. SEER Cancer Statistics
Review, 1975–2007. Bethesda, MD: National Cancer Institute,
2010.
5. Bardos JI and Ashcroft M. Negative and positive regulation
of HIF-1: a complex network. Biochim Biophys Acta 1755: 107–
120, 2005.
6. Bayreuther K, Francz PI, Gogol J, and Kontermann K.
Terminal differentiation, aging, apoptosis, and spontaneous
transformation in fibroblast stem cell systems in vivo and
in vitro. Ann N Y Acad Sci 663: 167–179, 1992.
7. Bhatia S, Tykodi SS, and Thompson JA. Treatment of met-
astatic melanoma: an overview. Oncology (Williston Park) 23:
488–496, 2009.
8. Boulares AH, Yakovlev AG, Ivanova V, Stoica BA, Wang G,
Iyer S, and Smulson M. Role of poly(ADP-ribose) polymer-
ase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP
mutant increases rates of apoptosis in transfected cells. J Biol
Chem 274: 22932–22940, 1999.
9. Brenneisen P, Wenk J, Klotz LO, Wlaschek M, Briviba K,
Krieg T, Sies H, and Scharffetter-Kochanek K. Central role of
ferrous/ferric iron in the ultraviolet B irradiation-mediated
signaling pathway leading to increased interstitial collage-
nase (matrix-degrading metalloprotease (MMP)-1) and
stromelysin-1 (MMP-3) mRNA levels in cultured human
dermal fibroblasts. J Biol Chem 273: 5279–5287, 1998.
10. Cat B, Stuhlmann D, Steinbrenner H, Alili L, Holtkotter O,
Sies H, and Brenneisen P. Enhancement of tumor invasion
depends on transdifferentiation of skin fibroblasts mediated
by reactive oxygen species. J Cell Sci 119: 2727–2738, 2006.
11. Celardo I, Traversa E, and Ghibelli. Cerium oxide nano-
particles: a promise for applications in therapy. J Exp Ther
Oncol 9: 47–51, 2011.
12. Deshpande S, Patil S, Kuchibhatla, SV, and Seal S. Size de-
pendency variation in lattice parameter and valency states in
nanocrystalline cerium oxide. Appl Phys Lett 87: 133113,
2005.
13. De Wever O and Mareel M. Role of myofibroblasts at the
invasion front. Biol Chem 383: 55–67, 2002.
14. Fang J, Nakamura H, and Iyer AK. Tumor-targeted induc-
tion of oxystress for cancer therapy. J Drug Target 15: 475–
486, 2007.
15. Freitas RA, Jr. What is nanomedicine? Nanomedicine 1: 2–9,
2005.
16. Fruehauf JP and Trapp V. Reactive oxygen species: an
Achilles’ heel of melanoma? Expert Rev Anticancer Ther 8:
1751–1757, 2008.
17. Gao W, Xu K, Ji L, and Tang B. Effect of gold nanoparticles
on glutathione depletion-induced hydrogen peroxide
generation and apoptosis in HL7702 cells. Toxicol Lett 205:
86–95, 2011.
18. Garbe C and Leiter U. Melanoma epidemiology and trends.
Clin Dermatol 27: 3–9, 2009.
19. Garbe C, Terheyden P, Keilholz U, Kolbl O, and Hauschild
A. Treatment of melanoma. Dtsch Arztebl Int 105: 845–851,
2008.
20. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH,
Dosik H, and Parks WP. In vitro cultivation of human tu-
mors: establishment of cell lines derived from a series of
solid tumors. J Natl Cancer Inst 51: 1417–1423, 1973.
21. Heckert EG, Karakoti AS, Seal S, and Self WT. The role of
cerium redox state in the SOD mimetic activity of nanoceria.
Biomaterials 29: 2705–2709, 2008.
22. Helmlinger G, Yuan F, Dellian M, and Jain RK. Interstitial
pH and pO2 gradients in solid tumors in vivo: high-
resolution measurements reveal a lack of correlation. Nat
Med 3: 177–182, 1997.
23. Jahroudi N and Greenberger JS. The role of endothelial cells
in tumor invasion and metastasis. J Neurooncol 23: 99–108,
1995.
24. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, and Thun
MJ. Cancer statistics, 2008. CA Cancer J Clin 58: 71–96, 2008.
25. Kappus H and Sies H. Toxic drug effects associated with
oxygen metabolism: redox cycling and lipid peroxidation.
Experientia 37: 1233–1241, 1981.
26. Karakoti AS, Satyanarayana VN, Kuchibhatla T, Babu KS,
and Seal S. Direct synthesis of nanoceria in aqueous poly-
hydroxyl solutions. J Phys Chem C 111: 17232–17240, 2007.
27. Karakoti AS, Monteiro-Riviere NA, Aggarwal R, Davis JP,
Narayan RJ, Self WT, McGinnis J, and Seal S. Nanoceria as
antioxidant: synthesis and biomedical applications. Jom
(1989) 60: 33–37, 2008.
28. Karakoti AS, Singh S, Dowding JM, Seal S, and Self WT.
Redox-active radical scavenging nanomaterials. Chem Soc
Rev 39: 4422–4432, 2010.
776 ALILI ET AL.
29. Kawiak A, Zawacka-Pankau J, Wasilewska A, Stasilojc G,
Bigda J, and Lojkowska E. Induction of apoptosis in HL-60
cells through the ROS-mediated mitochondrial pathway by
Ramentaceone from Drosera aliciae. J Nat Products 75: 9–14,
2012.
30. Kietzmann T and Gorlach A. Reactive oxygen species in the
control of hypoxia-inducible factor-mediated gene expres-
sion. Semin Cell Dev Biol 16: 474–486, 2005.
31. Korsvik C, Patil S, Seal S, and Self WT. Superoxide dis-
mutase mimetic properties exhibited by vacancy engineered
ceria nanoparticles. Chem Commun (Camb) 10: 1056–1058,
2007.
32. Kuchibhatla S, Karakoti AS, Bera D, and Seal S. One di-
mensional nanostructured materials. Prog Mater Sci 52: 699–
913, 2007.
33. Laemmli UK. Cleavage of structural proteins during the
assembly of the head of bacteriophage T4. Nature 227: 680–
685, 1970.
34. Laurent A, Nicco C, Chereau C, Goulvestre C, Alexandre J,
Alves A, Levy E, Goldwasser F, Panis Y, Soubrane O, Weill
B, and Batteux F. Controlling tumor growth by modulating
endogenous production of reactive oxygen species. Cancer
Res 65: 948–956, 2005.
35. Levi F, Boffetta P, and La Vecchia C. High constant inci-
dence rates of second primary neoplasms. Eur J Cancer Prev
17: 385–388, 2008.
36. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M,
Alnemri ES, and Wang X. Cytochrome c and dATP-depen-
dent formation of Apaf-1/caspase-9 complex initiates an
apoptotic protease cascade. Cell 91: 479–489, 1997.
37. Lin W, Huang YW, Zhou XD, and Ma Y. Toxicity of cerium
oxide nanoparticles in human lung cancer cells. Int J Toxicol
25: 451–457, 2006.
38. Luanpitpong S, Talbott SJ, Rojanasakul Y, Nimmannit U,
Pongrakhananon V, Wang L, and Chanvorachote P.
Regulation of lung cancer cell migration and invasion by
reactive oxygen species and caveolin-1. J Biol Chem 285:
38832–38840, 2010.
39. Ma1ecki JM, Bentke A, Ostrowska B, and Laidler P. Cyto-
chalasin D, LY294002 and olomoucine synergize in pro-
moting death of melanoma cells through activation of
caspase-3 and apoptosis. Melanoma Res 20: 52–58, 2010.
40. Mosmann T. Rapid colorimetric assay for cellular growth
and survival: application to proliferation and cytotoxicity
assays. J Immunol Methods 65: 55–63, 1983.
41. Nagata S. Apoptosis by death factor. Cell 88: 355–365, 1997.
42. Nangaku M, Izuhara Y, Takizawa S, Yamashita T, Fujii-
Kuriyama Y, Ohneda O, Yamamoto M, van Ypersele de
Strihou C, Hirayama N, and Miyata T. A novel class of
prolyl hydroxylase inhibitors induces angiogenesis and ex-
erts organ protection against ischemia. Arterioscler Thromb
Vasc Biol 27: 2548–2554, 2007.
43. Parums DV, Cordell JL, Micklem K, Heryet AR, Gatter KC,
and Mason DY. JC70: a new monoclonal antibody that
detects vascular endothelium associated antigen on rou-
tinely processed tissue sections. J Clin Pathol 43: 752–757,
1990.
44. Pirmohamed T, Dowding JM, Singh S, Wasserman B,
Heckert E, Karakoti AS, King JES, Seal S, and Self WT.
Nanoceria exhibit redox state-dependent catalase mimetic
activity. Chem Commun 46: 2736–2738, 2010.
45. Quiles JL, Huertas JR, Battino M, Mataix J, and Ramirez-
Tortosa MC. Antioxidant nutrients and adriamycin toxicity.
Toxicology 180: 79–95, 2002.
46. Reynolds ES. Use of lead citrate at high Ph as an electron-
opaque stain in electron microscopy. J Cell Biol 17: 208, 1963.
47. Roberts RA, Smith RA, Safe S, Szabo C, Tjalkens RB, and
Robertson FM. Toxicological and pathophysiological roles of
reactive oxygen and nitrogen species. Toxicology 276: 85–94,
2010.
48. Ruas JL and Poellinger L. Hypoxia-dependent activation of
HIF into a transcriptional regulator. Semin Cell Dev Biol 16:
514–522, 2005.
49. Sanchez Y, Amran D, de Blas E, and Aller P. Regulation of
genistein-induced differentiation in human acute myeloid
leukaemia cells (HL60, NB4) Protein kinase modulation and
reactive oxygen species generation. Biochem Pharmacol 77:
384–396, 2009.
50. Saphir A. Angiogenesis: the unifying concept in cancer? J
Natl Cancer Inst 89: 1658–1659, 1997.
51. Seo YH and Carroll KS. Profiling protein thiol oxidation in
tumor cells using sulfenic acid-specific antibodies. Proc Natl
Acad Sci U S A 106: 16163–16168, 2009.
52. Sies H. Strategies of antioxidant defense. Eur J Biochem 215:
213–219, 1993.
53. Sies H and Cadenas E. Oxidative stress—damage to intact-
cells and organs. Philos Transact R Soc London Ser B Biol Sci
311: 617–631, 1985.
54. Stolk J, Hiltermann TJ, Dijkman JH, and Verhoeven AJ.
Characteristics of the inhibition of NADPH oxidase activa-
tion in neutrophils by apocynin, a methoxy-substituted
catechol. Am J Respir Cell Mol Biol 11: 95–102, 1994.
55. Storz P. Reactive oxygen species in tumor progression. Front
Biosci 10: 1881–1896, 2005.
56. Stuhlmann D, Ale-Agha N, Reinehr R, Steinbrenner H,
Ramos MC, Sies H, and Brenneisen P. Modulation of
homologous gap junctional intercellular communication of
human dermal fibroblasts via a paracrine factor(s) gener-
ated by squamous tumor cells. Carcinogenesis 24: 1737–1748,
2003.
57. Swietach P, Vaughan-Jones RD, and Harris AL. Regulation
of tumor pH and the role of carbonic anhydrase 9. Cancer
Metastasis Rev 26: 299–310, 2007.
58. Tang Y, Zeng X, He F, Liao Y, Qian N, and Toi M. Caveolin-
1 is related to invasion, survival, and poor prognosis in
hepatocellular cancer. Med Oncol 29: 977–984, 2012.
59. Thannickal VJ, Aldweib KDL, and Fanburg BL. Tyrosine
phosphorylation regulates H2O2 production in lung fibro-
blasts stimulated by transforming growth factor beta 1. J Biol
Chem 273: 23611–23615, 1998.
60. Thannickal VJ and Fanburg BL. Reactive oxygen species in
cell signaling. Am J Physiol Lung Cell Mol Physiol 279: L1005–
L1028, 2000.
61. Thompson TC, Tahir SA, Li L, Watanabe M, Naruishi K,
Yang G, Kadmon D, Logothetis CJ, Troncoso P, Ren C,
Goltsov A, and Park S. The role of caveolin-1 in prostate
cancer: clinical implications. Prostate Cancer Prostatic Dis 13:
6–11, 2010.
62. Tomayko MM and Reynolds CP. Determination of subcu-
taneous tumor size in athymic (nude) mice. Cancer Chemother
Pharmacol 24: 148–154, 1989.
63. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, and
Telser J. Free radicals and antioxidants in normal physio-
logical functions and human disease. Int J Biochem Cell Biol
39: 44–84, 2007.
64. Wittgen HG and van Kempen LC. Reactive oxygen species
in melanoma and its therapeutic implications. Melanoma Res
17: 400–409, 2007.
EFFECT OF POLYMER-COATED NANOPARTICLES ON CHEMOPREVENTION 777
65. Woiniak A, Drewa G, Wozniak B, Schachtschabel DO, Mila-
Kierzenkowska C, Drewa T, Olszewska-Slonina D, and So-
ponska M. The effect of antitumor drugs on oxidative stress
in B16 and S91 melanoma cells in vitro. Med Sci Monit 11:
BR22– BR29, 2005.
66. Zhou M, Diwu Z, Panchuk-Voloshina N, and Haugland RP.
A stable nonfluorescent derivative of resorufin for the fluo-
rometric determination of trace hydrogen peroxide: appli-
cations in detecting the activity of phagocyte NADPH









Date of first submission to ARS Central, July 19, 2012; date of
final revised submission, November 14, 2012; date of accep-
tance, December 1, 2012.
Abbreviations Used
aSMA¼ a-smooth muscle actin
A375¼human malignant melanoma cells
Cav-1¼ caveoline-1
CM¼ conditioned medium
CNP¼ cerium oxide nanoparticles
CoCl2¼ cobalt chloride
Da¼Dalton
DMEM¼Dulbecco’s modified Eagle’s medium
DNP¼dinitrophenyl
FCS¼ fetal calf serum
FITC¼fluorescein isothiocyanate
FTIR¼ Fourier transform infrared spectroscopy











ROS¼ reactive oxygen species
rTGFb1¼ recombinant transforming growth factor b1
SDS¼ sodium dodecyl sulfate
SDS-PAGE¼ sodium dodecyl sulfate–polyacrylamide
gel electrophoresis
SEM¼ standard error of the mean
SOD¼ superoxide dismutase
TEM¼ transmission electron microscopy
XPS¼X-ray photoelectron spectroscope
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